| 2026-01-07 |
13D/A |
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) |
Bpifrance Participations SA |
10,898,595 |
4.70 |
-0.79 |
| 2026-01-05 |
13D/A |
EXEL / Exelixis, Inc. |
Farallon Capital Partners, L.P. |
15,709,500 |
5.90 |
-15.70 |
| 2026-01-05 |
13D/A |
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) |
Bpifrance Participations SA |
10,985,372 |
5.30 |
-22.01 |
| 2026-01-02 |
13D |
INAB / IN8bio, Inc. |
Emily Fairbairn |
733,293 |
7.50 |
|
| 2026-01-02 |
13D/A |
MGTX / MeiraGTx Holdings plc |
Perceptive Advisors Llc |
10,441,562 |
12.90 |
-17.76 |
| 2025-12-29 |
13D/A |
IVVD / Invivyd, Inc. |
Adimab, LLC |
20,262,170 |
7.30 |
-0.94 |
| 2025-12-23 |
13D/A |
RXRX / Recursion Pharmaceuticals, Inc. |
Mubadala Investment Co PJSC |
7,062,869 |
1.40 |
-37.45 |
| 2025-12-23 |
13D |
VOR / Vor Biopharma Inc. |
ForGrowth III PA B.V. |
10,237,714 |
9.99 |
46.25 |
| 2025-12-19 |
13D/A |
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) |
Bpifrance Participations SA |
14,086,283 |
6.80 |
-19.30 |
| 2025-12-19 |
13D/A |
KOD / Kodiak Sciences Inc. |
Baker Bros. Advisors Lp |
20,067,542 |
32.80 |
15.64 |
| 2025-12-18 |
13D/A |
VOR / Vor Biopharma Inc. |
Ra Capital Management, L.p. |
5,411,521 |
14.00 |
130.74 |
| 2025-12-17 |
13D/A |
TNYA / Tenaya Therapeutics, Inc. |
Column Group Iii, Lp |
49,313,559 |
23.10 |
0.00 |
| 2025-12-15 |
13D/A |
KYMR / Kymera Therapeutics, Inc. |
Biotechnology Value Fund L P |
6,867,809 |
8.50 |
17.78 |
| 2025-12-15 |
13D/A |
ELUT / Elutia Inc. |
Highcape Partners, L.p. |
5,244,056 |
13.00 |
|
| 2025-12-12 |
13D/A |
IMVT / Immunovant, Inc. |
Roivant Sciences Ltd. |
113,327,007 |
55.90 |
17.24 |
| 2025-12-12 |
13D/A |
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) |
Bpifrance Participations SA |
10,599,440 |
11.10 |
2.98 |
| 2025-12-11 |
13D/A |
KYMR / Kymera Therapeutics, Inc. |
Baker Bros. Advisors Lp |
8,676,797 |
10.90 |
30.15 |
| 2025-11-19 |
13D/A |
IVVD / Invivyd, Inc. |
Adimab, LLC |
20,454,490 |
8.80 |
-5.69 |
| 2025-11-14 |
13D/A |
VOR / Vor Biopharma Inc. |
Ra Capital Management, L.p. |
2,345,277 |
9.90 |
189.30 |
| 2025-11-14 |
13D/A |
LCTX / Lineage Cell Therapeutics, Inc. |
Broadwood Partners, L.p. |
57,848,357 |
23.10 |
0.00 |
| 2025-11-14 |
13D/A |
ATRA / Atara Biotherapeutics, Inc. |
Redmile Group, LLC |
751,223 |
9.90 |
6.53 |
| 2025-11-12 |
13D/A |
IVVD / Invivyd, Inc. |
Mithril Ii Lp |
11,241,580 |
4.80 |
|
| 2025-11-12 |
13D/A |
NVAX / Novavax, Inc. |
Shah Capital Management |
13,461,780 |
8.30 |
13.97 |
| 2025-11-12 |
13D/A |
GLUE / Monte Rosa Therapeutics, Inc. |
Versant Venture Capital VI, L.P. |
3,334,669 |
5.10 |
-18.26 |
| 2025-11-10 |
13D/A |
IBRX / ImmunityBio, Inc. |
Cambridge Equities, LP |
743,971,200 |
68.90 |
6.87 |
| 2025-11-07 |
13D/A |
IVVD / Invivyd, Inc. |
Polaris Venture Partners V, L.P. |
7,008,590 |
3.00 |
-13.42 |
| 2025-11-04 |
13D/A |
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) |
Bpifrance Participations SA |
17,455,376 |
9.40 |
0.00 |
| 2025-10-30 |
13D/A |
VOR / Vor Biopharma Inc. |
Ra Capital Management, L.p. |
810,671 |
11.50 |
-31.68 |
| 2025-10-30 |
13D/A |
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock) |
Sofinnova Crossover I |
8,399,478 |
9.40 |
-12.50 |
| 2025-10-29 |
13D/A |
NMRA / Neumora Therapeutics, Inc. |
ARCH Venture Fund VII, L.P. |
33,958,967 |
20.70 |
|
| 2025-10-28 |
13D/A |
CGON / CG Oncology, Inc. |
Seven Fleet Capital Management LP |
1,542,833 |
2.00 |
|
| 2025-10-27 |
13D/A |
VOR / Vor Biopharma Inc. |
Ra Capital Management, L.p. |
1,186,500 |
17.30 |
-17.18 |
| 2025-10-24 |
13D/A |
ENZN / Viskase Holdings, Inc. |
Icahn Carl C |
36,056,636 |
48.60 |
0.00 |
| 2025-10-20 |
13D/A |
VOR / Vor Biopharma Inc. |
Ra Capital Management, L.p. |
1,432,693 |
20.90 |
-27.96 |
| 2025-10-17 |
13D/A |
VOR / Vor Biopharma Inc. |
Reprogrammed Interchange LLC |
1,204,442 |
17.60 |
-12.39 |
| 2025-10-14 |
13D/A |
APGE / Apogee Therapeutics, Inc. |
Fairmount Funds Management LLC |
5,776,881 |
9.99 |
21.30 |
| 2025-10-14 |
13D/A |
NVAX / Novavax, Inc. |
Shah Capital Management |
11,811,780 |
7.30 |
7.08 |
| 2025-10-10 |
13D/A |
VOR / Vor Biopharma Inc. |
Reprogrammed Interchange LLC |
1,374,775 |
20.10 |
-8.28 |
| 2025-10-08 |
13D/A |
VOR / Vor Biopharma Inc. |
Reprogrammed Interchange LLC |
1,498,921 |
21.90 |
-6.16 |
| 2025-10-07 |
13D/A |
SRRK / Scholar Rock Holding Corporation |
Samsara BioCapital, L.P. |
6,991,553 |
7.20 |
3.47 |
| 2025-10-06 |
13D/A |
VOR / Vor Biopharma Inc. |
Reprogrammed Interchange LLC |
1,597,308 |
23.30 |
-95.29 |
| 2025-10-03 |
13D |
SABS / SAB Biotherapeutics, Inc. |
Ra Capital Management, L.p. |
4,401,500 |
9.90 |
|
| 2025-09-23 |
13D/A |
CGTX / Cognition Therapeutics, Inc. |
BIOS Memory SPV I, LP |
6,059,555 |
6.90 |
0.89 |
| 2025-09-23 |
13D/A |
JSPR / Jasper Therapeutics, Inc. |
Velan Capital Master Fund LP |
2,668,395 |
9.60 |
|
| 2025-09-19 |
13D/A |
VOR / Vor Biopharma Inc. |
Ra Capital Management, L.p. |
1,988,657 |
29.00 |
|
| 2025-09-18 |
13D |
CGON / CG Oncology, Inc. |
Longitude Capital Partners IV, LLC |
4,662,268 |
6.00 |
-0.00 |
| 2025-09-18 |
13D |
CGON / CG Oncology, Inc. |
Seven Fleet Partners LP |
1,515,151 |
2.00 |
|
| 2025-09-12 |
13D/A |
VOR / Vor Biopharma Inc. |
Reprogrammed Interchange LLC |
33,928,487 |
26.80 |
-4.36 |
| 2025-09-09 |
13D/A |
VOR / Vor Biopharma Inc. |
Reprogrammed Interchange LLC |
35,476,939 |
28.00 |
-3.82 |
| 2025-09-05 |
13D/A |
VALN / Valneva SE - Depositary Receipt (Common Stock) |
Bpifrance Participations SA |
21,810,176 |
11.60 |
54.53 |